ER stress pathways regulate T-cell allogeneic and anti-tumor responses
ER stress pathways regulate T-cell allogeneic and anti-tumor responses
批准号:
10577856
负责人:
Xue-Zhong Yu
金额:
$17.87万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-01 至 2024-02-29
关键词:
ATF6 geneAddressAllogenicAntibodiesAntigen-Presenting CellsAntigensAntitumor ResponseB-LymphocytesBiologyCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell SurvivalCellsDataDegenerative DisorderDendritic CellsDiseaseEndoplasmic ReticulumEnvironmentExhibitsFoundationsGenetic TranscriptionGoalsHealthHematologic NeoplasmsHomeostasisHumanImmune responseImmune systemImmunityIn VitroInflammatoryKnock-outKnowledgeLearningMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMetabolic DiseasesMitochondriaMusPathogenicityPathway interactionsPlayProteinsPublishingRegulationReportingRoleSignal TransductionSolidSolid NeoplasmSyngeneic Bone Marrow TransplantationT cell responseT-LymphocyteTestingantigen processingcancer cellcancer immunotherapychimeric antigen receptor T cellsconditional knockouteffector T cellendoplasmic reticulum stressexhaustionexperimental studygraft versus host disease inductiongraft vs host diseasegraft vs leukemia effectimprovedin vivoleukemianovel strategiesprogramsprotein misfoldingresponsetumortumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Unfolded protein response (UPR) is a highly conserved pathway that allows the cell to manage endoplasmic
reticulum (ER) stress in response to protein misfolding. Three master regulators control the UPR: IRE1α,
PERK, and ATF6. The primary goal of UPR is to induce transcriptional and translational programs to maintain
ER homeostasis for cell survival. Thus, dysfunctional UPR signaling has been shown to contribute to various
health conditions including metabolic diseases, degenerative diseases, inflammatory disorders, and cancer.
The ER stress pathways have been studied in cancer cells extensively, but have been overall understudied in
T-cell immunity and tolerance. There are several knowledge gaps in understanding the impacts of the ER
stress pathways in T-cell immunity against cancer. Our long-term goal is to develop novel strategies through
targeting the ER stress pathways for improving cancer immunotherapy of human malignancies. the overall
objectives of this application are to provide critical information towards more understanding the impacts of ER
stress pathways on immune responses against cancer, which will eventually help to fulfill our long-term goal.
Our central hypothesis is that the IRE-1α/XBP-1 and PERK/CHOP pathways differentially regulate CD4 and
CD8 anti-tumor responses in microenvironment dependent manner. The hypothesis has been formulated
based on preliminary data generated from in vitro and in vivo experiments using genetically modified mice with
T-cell conditional knock-out (KO) for XBP-1, PERK or both. This hypothesis will be tested in the following two
Specific Aims: 1) To define the role of XBP-1 and PERK in T-cell mediated graft-versus-host (GVH) and graft-
versus-leukemia (GVL) responses; 2) To define the impact of XBP-1 and PERK in T-cell immunity against
tumor. The proposed study is expected to provide a strong guidance for improving T-cell based cancer
immunotherapy by targeting the ER stress pathways and to provide a solid foundation for further studying
underlying mechanisms of ER stress pathways in regulating T-cell immunity.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
-
批准号:10364948
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2022
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
-
批准号:10559633
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2022
-
负责人:Xue-Zhong Yu
-
依托单位:
ER stress pathways regulate T-cell allogeneic and anti-tumor responses
-
批准号:10430505
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2022
-
负责人:Xue-Zhong Yu
-
依托单位:
Control of GVHD by Probiotics with individual Commensal Bacteria
-
批准号:10434993
-
项目类别:
-
资助金额:$62.39万
-
财政年份:2022
-
负责人:Xue-Zhong Yu
-
依托单位:
Control of GVHD by Probiotics with individual Commensal Bacteria
-
批准号:10617324
-
项目类别:
-
资助金额:$61.35万
-
财政年份:2022
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
-
批准号:10578550
-
项目类别:
-
资助金额:$51.28万
-
财政年份:2018
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
-
批准号:10179448
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2018
-
负责人:Xue-Zhong Yu
-
依托单位:
Separation of GVH and GVL Responses Using Alloreactive CD8 iTregs
-
批准号:9333524
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2017
-
负责人:Xue-Zhong Yu
-
依托单位:
Control of GVHD and Leukemia Relapse by Targeting Cell Metabolism
-
批准号:8815578
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2015
-
负责人:Xue-Zhong Yu
-
依托单位:
MicroRNA Regulates Graft-versus-Host Disease
-
批准号:9206138
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2015
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IL-12/23 p40 Pathways for the Control of GVHD
-
批准号:8691100
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2013
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IL-12/23 p40 Pathways for the Control of GVHD
-
批准号:8446757
-
项目类别:
-
资助金额:$13.37万
-
财政年份:2013
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IL-12/23 p40 Pathways for the Control of GVHD
-
批准号:9001926
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2013
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IL-12/23 p40 Pathways for the Control of GVHD
-
批准号:9208123
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2013
-
负责人:Xue-Zhong Yu
-
依托单位:
Targeting IL-12/23 p40 Pathways for the Control of GVHD
-
批准号:8628807
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2013
-
负责人:Xue-Zhong Yu
-
依托单位:
Th1/Th17 Cell Differentiation in GVHD and GVL
-
批准号:8074961
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2010
-
负责人:Xue-Zhong Yu
-
依托单位:
Th1/Th17 Cell Differentiation in GVHD and GVL
-
批准号:8458597
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2010
-
负责人:Xue-Zhong Yu
-
依托单位:
Th1/Th17 Cell Differentiation in GVHD and GVL
-
批准号:8247072
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2010
-
负责人:Xue-Zhong Yu
-
依托单位:
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
-
批准号:8717592
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2006
-
负责人:Xue-Zhong Yu
-
依托单位:
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
-
批准号:8286896
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2006
-
负责人:Xue-Zhong Yu
-
依托单位:
海外基金